Medical Policy and Coding Updates - October 2026
Premera's October 2026 medical policy update covers new, revised and deleted medical policies, pharmacy policies, and coding changes with effective dates from October 1, 2026 through January 1, 2027. Several policies now require medical necessity review and prior authorization, including Denosumab Products (5.01.658), Miscellaneous Oncology Drugs (5.01.540) and ALK Tyrosine Kinase Inhibitors (5.01.638), and Bioengineered Skin and Soft Tissue Substitutes (7.01.582) and Laboratory Testing Investigational Services (2.04.520) are now considered investigational. Changes dated October 1, 2026 are already effective, and changes dated November 6, 2026 and later are future changes.